Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
94 Results for "
mouse interferon
" in MedChemExpress (MCE) Product Catalog:
Products (94)
94 Results for "mouse interferon" in MCE Product Catalog:
1
1
1
1
1 Cited Publications
Cat. No.: HY-P700183AF
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IFNA1; interferon Alpha-1; interferon Alpha 1; interferon Alpha-D; IFN-AlphaD; interferon-Alpha1; IFN-ALPHA; IFN-Alpha-1; IFNA13; LeIF D; IFNA@; interferon Alpha-1/13; IFL; IFN-Alpha-1/13; IFN; IFN-Alpha 1b; interferon Alpha 1b
Species:
Mouse
Source:
E. coli
1
1 Cited Publications
Cat. No.: HY-P70642
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL18; Interleukin 18 (interferon-Gamma-Inducing Factor); Interleukin 18; IFN-Gamma-Inducing Factor; IL-18; Interleukin-1 Gamma; IL1F4; Iboctadekin; IGIF; IL-1 Gamma; Interleukin-18; interferon-Gamma-Inducing Factor; IL-1g; interferon Gamma-Inducing Factor
Species:
Mouse
Source:
E. coli
1
1 Cited Publications
Cat. No.: HY-P7378
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (interferon, Beta 2); HGF; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; interferon, Beta 2; CTL Differ
Species:
Mouse
Source:
CHO
1
1 Cited Publications
Cat. No.: HY-P700216AF
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma Growth Factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (interferon, Beta 2); HGF; B-Cell Differentiation Factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory Factor 2; interferon, Beta 2; CTL Differ
Species:
Mouse
Source:
E. coli
1
1 Cited Publications
Cat. No.: HY-P7227
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CXCL10; Small Inducible Cytokine Subfamily B (Cys-X-Cys), Member 10; Prev. SCYB10; Small-Inducible Cytokine B10; Prev. INP10; C-X-C Motif Chemokine 10; IP-10; Protein 10 From interferon (Gamma)-Induced Cell Line; GIP-10; interferon-Inducible Cytokine IP-10; Mob-1; Chemokine (C-X-C Motif) Ligand 10; Crg-2; Gamma IP10; IFI10; Gamma-IP10; C7; C-X-C Motif Chemokine Ligand 10; 10 KDa interferon Gamma-Induced Protein
Species:
Mouse
Source:
E. coli
1
1 Cited Publications
Cat. No.: HY-P700169AF
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CXCL11; interferon Gamma-Inducible Protein 9; Prev. SCYB11; C-X-C Motif Chemokine 11; Prev. SCYB9B; Beta-R1; I-TAC; Small Inducible Cytokine Subfamily B (Cys-X-Cys), Member 9B; H174; Small Inducible Cytokine B11; IP-9; Small-Inducible Cytokine B11; B-R1;
Species:
Mouse
Source:
E. coli
Cat. No.: HY-177338
CAS No.: 2361424-97-5
Research Areas:
STING agonist-45 is a selective STING agonist (EC50 = 0.28 μM). STING agonist-45 activates the innate immune response through the cGAS-STING pathway, upregulating key markers such as p-TBK1 and IRF3. STING agonist-45 exhibits robust STING activation in human peripheral blood mononuclear cells (PBMCs), inducing the production of type I interferons (such as IFN-β) and downstream cytokines (such as TNF-α and IL-6). STING agonist-45 enhances anti-tumor immunity, inhibits tumor growth, and increases CD8 + T cell infiltration in mouse models. STING agonist-45 is promising for the study of STING-related diseases .
Cat. No.: HY-176222
Target:
Research Areas:
IRF1 antagonist 1 (8003-3282) is a potent IRF1 (interferon regulatory factor) antagonist with anti-inflammatory activity. IRF1 antagonist 1 can maintain blood-brain barrier integrity and reduce brain edema. IRF1 antagonist 1 can improve neurological outcomes in an acute traumatic brain injury (TBI) mouse model .
Cat. No.: HY-P991278
Target:
Research Areas:
Cat. No.: HY-P99809
CAS No.: 2254059-25-9
Synonyms: MK-1308
Cat. No.: HY-P990839
Target:
Research Areas:
Cat. No.: HY-174136
Research Areas:
STING Degrader-2 is an orally active STING degrader that promotes proteasome-independent degradation of STING. STING Degrader-2 inhibits cGAMP-induced STING activation, suppresses STING oligomerization, and inhibits phosphorylation of STING and interferon regulatory factor 3 (IRF3). STING Degrader-2 reduces serum IFN-β and CXCL-10 levels in a cGAMP-induced autoimmune disease mouse model. STING Degrader-2 can be used for the research of autoimmune diseases .
Cat. No.: HY-P990233
Target:
Research Areas:
Cat. No.: HY-P990163
Target:
Research Areas:
Cat. No.: HY-163749
Target:
Research Areas:
STING-IN-8 (Compound 15b) emerges as a potent stimulator of interferon gene (STING) inhibitor with an IC50 value of 0.121 μM in human and an IC50 value of 0.033 μM in mouse. STING-IN-8 inhibits MSA-2 (HY-136927) or 2’, 3’ -cGAMP (HY-100564)-stimulated STING signaling and suppresses immune-inflammatory cytokine levels in both human and murine cells. STING-IN-8 is promising for research in the field of STING-associated inflammatory and autoimmune diseases .
Cat. No.: HY-155109
CAS No.: 2757762-91-5
Target:
Research Areas:
Antitumor agent-114 is a potent stimulator of interferon genes (STING) agonist. Antitumor agent-114 activates immunity and reduces tumor volume in a mouse model of breast cancer. Antitumor agent-114 can be used for immunity and cancer diseases research .
Cat. No.: HY-N2939
CAS No.: 870480-56-1
Target:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
